Close

Analyst Ratings for Protagonist Therapeutics (PTGX) [Neutrals]

PTGX Rating Summary

PTGX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PTGX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $40.33 (+50.2%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 90%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/6/2018 Barclays N/A Downgrade Equalweight
(Overweight)
8.50
(30.00)
7.29
(26.85)
268.31% Details